Plegridy

E24878

Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.

AI illustration

How this image was made

AI-generated illustration of Plegridy

This AI-generated illustration was produced by black-forest-labs/FLUX.2-dev (1024x1024) from a prompt written by openai/gpt-oss-120b from the entity's label + description.

Prompt

Generate an image of a plegridy (Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.)

All labels observed (1)

Label Occurrences
Plegridy canonical 2

How this entity was disambiguated

Statements (51)

Predicate Object
instanceOf disease-modifying therapy ⓘ
medication ⓘ
pegylated interferon beta-1a ⓘ
activeIngredient peginterferon beta-1a ⓘ
belongsToClass immunomodulatory agents ⓘ
interferon beta-1a ⓘ
hasAdministrationFrequency every 14 days ⓘ
hasApprovalAuthority European Medicines Agency ⓘ
U.S. Food and Drug Administration ⓘ
hasATCCode L03AB13 ⓘ
hasBlackBoxWarning risk of depression and suicide ⓘ
risk of hepatotoxicity ⓘ
hasCommonSideEffect chills ⓘ
flu-like symptoms ⓘ
headache ⓘ
injection site reactions ⓘ
myalgia ⓘ
pyrexia ⓘ
hasContraindication history of suicidal ideation ⓘ
severe depression ⓘ
severe hepatic impairment ⓘ
hasDeveloper Biogen ⓘ
hasDosageForm pre-filled pen ⓘ
pre-filled syringe ⓘ
solution for injection ⓘ
hasEffect reduces MRI lesion activity ⓘ
reduces relapse rate in multiple sclerosis ⓘ
slows disability progression ⓘ
hasLegalStatusEU prescription only ⓘ
hasLegalStatusUS prescription only ⓘ
hasManufacturer Biogen ⓘ
hasMechanismOfAction immunomodulation ⓘ
reduction of inflammatory responses in multiple sclerosis ⓘ
hasPregnancyCategoryUS C ⓘ
hasRouteOfAdministration subcutaneous ⓘ
subcutaneous injection ⓘ
hasSeriousSideEffect depression ⓘ
hepatotoxicity ⓘ
pulmonary arterial hypertension ⓘ
suicidal ideation ⓘ
thrombotic microangiopathy ⓘ
hasTradeName Plegridy ⓘ
isAdministeredTo adults ⓘ
isPegylated true ⓘ
isUsedFor long-term treatment of multiple sclerosis ⓘ
treats active secondary progressive multiple sclerosis ⓘ
clinically isolated syndrome ⓘ
relapsing forms of multiple sclerosis ⓘ
relapsing-remitting multiple sclerosis ⓘ
wasApprovedInEU 2014 ⓘ
wasApprovedInUS 2014 ⓘ

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Biogen → hasProduct → Plegridy ⓘ
Plegridy → hasTradeName → Plegridy ⓘ